- Home
- BFRI vs UPXI Comparison
BFRI vs UPXI Comparison
Compare BFRI & UPXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRI
- UPXI
- Stock Information
- Founded
- BFRI 1997
- UPXI 2018
- Country
- BFRI United States
- UPXI United States
- Employees
- BFRI N/A
- UPXI N/A
- Industry
- BFRI Biotechnology: Pharmaceutical Preparations
- UPXI Medicinal Chemicals and Botanical Products
- Sector
- BFRI Health Care
- UPXI Health Care
- Exchange
- BFRI Nasdaq
- UPXI Nasdaq
- Market Cap
- BFRI 6.2M
- UPXI 5.1M
- IPO Year
- BFRI 2021
- UPXI 2021
- Fundamental
- Price
- BFRI $0.98
- UPXI $3.76
- Analyst Decision
- BFRI Strong Buy
- UPXI Hold
- Analyst Count
- BFRI 1
- UPXI 1
- Target Price
- BFRI $7.00
- UPXI $25.00
- AVG Volume (30 Days)
- BFRI 990.2K
- UPXI 108.5K
- Earning Date
- BFRI 11-13-2024
- UPXI 02-12-2025
- Dividend Yield
- BFRI N/A
- UPXI N/A
- EPS Growth
- BFRI N/A
- UPXI N/A
- EPS
- BFRI N/A
- UPXI N/A
- Revenue
- BFRI $35,358,000.00
- UPXI $22,082,477.00
- Revenue This Year
- BFRI $17.69
- UPXI $299.03
- Revenue Next Year
- BFRI $19.71
- UPXI N/A
- P/E Ratio
- BFRI N/A
- UPXI N/A
- Revenue Growth
- BFRI 5.17
- UPXI N/A
- 52 Week Low
- BFRI $0.61
- UPXI $2.17
- 52 Week High
- BFRI $3.90
- UPXI $33.00
- Technical
- Relative Strength Index (RSI)
- BFRI 52.63
- UPXI 40.19
- Support Level
- BFRI $0.94
- UPXI $3.55
- Resistance Level
- BFRI $1.06
- UPXI $7.30
- Average True Range (ATR)
- BFRI 0.12
- UPXI 0.69
- MACD
- BFRI -0.01
- UPXI -0.12
- Stochastic Oscillator
- BFRI 28.89
- UPXI 6.90
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.
About UPXI Upexi Inc.
Upexi Inc is an innovator in aggregation, accelerating Amazon and eCommerce businesses by combining consumer data and vertical integration to scale brands in multiple industries, while lowering costs with a growing distribution network.